Earlier this month it was announced that RWS Holdings plc had completed the acquisition of SDL plc, in what will be a transformational combination for both companies. The combined group is the largest language services and software company in the world with a market capitalization of over £2 billion.
The transaction benefits RWS and SDL customers alike, as it brings together broad capabilities across a range of language services, language and content software and IP services, combining the complementary strengths of RWS’ specialist technical translation and localization capabilities with SDL’s software, machine translation and AI capabilities.
The combined group enhances both groups’ proposition, enabling customers to benefit from broader and enhanced capabilities, increased scale, expanded geographic footprint and a highly experienced management team.
As a well-funded, cash generative business with a strong balance sheet, the combined group will also continue to invest organically and in acquisitions that will further enhance its customer offering.
Richard Thompson, CEO of RWS, commented: “This is an exciting time for our joint customer base. The creation of the world’s leading language services and technology group allows us to provide a broader and enhanced offering to an expanded client audience. The combined company will have technology at its heart, underpinned with specialist capabilities, quality and an unwavering commitment to customer service.
“We look forward to working with our valued customers to continue to enhance the way we serve their needs.”
About RWS Holdings:
RWS is publicly listed on AIM, the London Stock Exchange regulated market (RWS.L), with offices across five continents. Prior to its acquisition of SDL, RWS had strong market positions in three growing markets:
IP Services – premier provider of intellectual property support services (patent translations, international patent filing solutions and searches) with over 200 full-time linguists (in-house translators, checkers, QA).
Life Sciences – provides life sciences translations and linguistic validation with an exclusive focus on pharma, biotech, medical device companies and CROs.
Moravia – a highly experienced localization provider, with customized localization programs and innovative technology solutions.
With an expanded geographical footprint across the US, UK, continental Europe, Asia, Canada and South America, the combined group will serve an expanded blue-chip customer base, including 90 of the world’s top 100 brands, all the top 10 pharmaceutical companies, a number of the largest global technology firms and approximately half of the top 20 patent filers worldwide. The combined group will have technology at its heart, underpinned with specialist capabilities, quality and an unwavering commitment to customer service, built upon each company’s legacy, culture and people.